A case study of lung cancer patients in term of various risk factors in context of Bangladesh

A case study of lung cancer patients in term of various risk factors in context of Bangladesh

This thesis is submitted in partial fulfilment of the requirements for the degree of Bachelor of Science in Microbiology, 2018.

Dades bibliogràfiques
Autor principal:	Shabnam, Musharrat
Altres autors:	Islam, Mohammad Rafiqul
Format:	Thesis
Idioma:	English
Publicat:	BRAC University 2018
Matèries:	Lung cancer Chronic obstructive pulmonary disease Ahsania Mission Cancer Hospital Lungs - Cancer HEALTH & FITNESS - Diseases - Cancer MEDICAL - Oncology.
Accés en línia:	http://hdl.handle.net/10361/10726

Ítems similars

Molecules associated with the development of lung cancer
per: Rahman, Adree, et al.
Publicat: (2023)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
per: Pial, Sazia Afrin
Publicat: (2018)

Protein biomarkers for Lung Cancer: a bioinformatic approach
per: Jeba, Joynob
Publicat: (2017)

A review on targeted therapies for lung cancer
per: Ashraf, Anushey
Publicat: (2023)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
per: Bristy, Israt Zerin
Publicat: (2021)

Potential of liposomes for the treatment of lung cancer- a review
per: Mim, Shanzida
Publicat: (2023)

A review on recent advances in drugs for lung cancer treatment
per: Noor, Fouzia
Publicat: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
per: Rahman, Tasnim
Publicat: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
per: Razna, Amrin Islam
Publicat: (2019)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
per: Tania, Umme
Publicat: (2023)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
per: Hoque, Ismoth Ara
Publicat: (2024)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
per: Paul, Pulock
Publicat: (2024)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
per: Zangmo, Thinley
Publicat: (2024)

Immunotherapy in the Management of Lung Cancer
per: Tasnim, Humayra
Publicat: (2022)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
per: Flora, Sanzida Alam
Publicat: (2024)

Lung cancer detection and classification using machine learning
per: Arefin, Mahbubul, et al.
Publicat: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
per: Das, Reshita
Publicat: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
per: Roy, Hredita
Publicat: (2018)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
per: F. S. Amaral, André, et al.
Publicat: (2017)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
per: Rahman, Sanjida
Publicat: (2024)

Prevalence and risk factors of chronic obstructive pulmonary disease in Bangladesh: A systematic review
per: Sutradhar, Ipsita, et al.
Publicat: (2022)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
per: Hossain, Safa Binte
Publicat: (2019)

Statistics and informatics in molecular cancer research

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
per: Nawar, Anika
Publicat: (2019)

Cancer risk factors: a critical review
per: Tabassum, Tahsina
Publicat: (2017)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
per: Mukti, Roushney Fatima, et al.
Publicat: (2016)

The current cancer situation in metropolitan Dhaka
per: Morshid, Golam
Publicat: (2023)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
per: Rithin, Rafia Islam
Publicat: (2022)

A brief survey on the effect of smoke of different sources on COPD patients
per: Nawal, Nusrat
Publicat: (2021)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
per: Nandy, Aditi
Publicat: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
per: Abir, Shifaty Nur
Publicat: (2024)

Targeting BRAFV600E in the treatment of CRC
per: Roja, Mashwiyat Samrin
Publicat: (2024)

Application of NSAIDs in the treatment of pulmonary diseases- a comparative study of the therapeutic & the adverse impacts
per: Rahman, Farhana
Publicat: (2021)

Role of statins as antagonists of SPARC in gastric cancer
per: Shahmat, Rad
Publicat: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
per: Karim, Samia Binte
Publicat: (2024)

Epigenetic therapy in cancer
per: Abid, Md. Shadman Ridwan
Publicat: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
per: Khondokar, Faiza
Publicat: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
per: Jahan, Nusrat
Publicat: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
per: Raihan, Dilraj
Publicat: (2024)

Biosimilar in lymphoma treatment
per: Tanisha, Mehrin Haque
Publicat: (2021)